LIVing Donor Allograft for Anterior Cruciate Ligament Reconstruction Study
ConditionACL
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age8-17
SponsorMaidstone & Tunbridge Wells NHS Trust
About this trial
The Anterior Cruciate Ligament (ACL) is a major stabiliser of the knee. ACL rupture is being increasingly identified in children and skeletally immature patients. The current advice in younger patients is usually to undergo ACL reconstruction. The choice of an ideal graft in children is difficult
This study will use a technique involves the use of hamstring tendons from a living donor, where the adult (usually a parent) agrees to donate their hamstring tendons, which are dissected out of them and implanted into the child
Eligibility criteria
Qualifiers
Patients aged 8 to 17 years inclusive and have a clinically and radiologically confirmed ACL rupture that requires reconstruction.
Patients who have had previous surgery for meniscal pathology .
Patients with current meniscal pathology
The child and their responsible adult are in agreement with the choice to undergo anterior cruciate ligament reconstruction using living donor allograft.
Disqualifiers
Patients who have previously undergone ACL surgery on the same limb (and therefore require revision surgery)
Patients who are immunosuppressed, or receiving immunosuppressive therapy
Patients who are unable to attend follow-up appointments for continued research purposes.
Donors who have previously undergone hamstring tendon surgery on the donor limb
Trial design
Treatments tested in this trial
- Endoscopic Anterior Cruciate Ligament reconstruction using living donor hamstring allograft from a parent donor
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov